Blueprint Medicines Corporation Earning Date (BPMC)

USA |NASDAQ |USD

BPMC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 15, 2022 Dec 2021 $-1.54 - $-1.53
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 15, 2022 Dec 2021 $56.49M - $34.11M

Blueprint Medicines Corporation's next earnings date is Tuesday, Feb 15, 2022 for the fiscal quarter ending Dec 2021.

BPMC Earnings Date & History Chart

BPMC Earnings & Revenue Forecast

BPMC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $-1.54 $-1.92 $-1.20
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $-6.66 $-7.39 $-5.82
Dec 2022 14 $-6.41 $-8.62 $-4.34

BPMC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-1.54 $-1.54 $-1.53
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-6.61 $-6.61 $-6.61
Dec 2022 0 / 1 $-6.19 $-6.19 $-5.85

BPMC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 13 $56.49M $39.30M $77.30M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 13 $148.37M $119.10M $159.50M
Dec 2022 13 $246.43M $139.40M $440.60M

BPMC Earnings Date & Revenue History

BPMC Earnings History

|
Show More
Show More

BPMC Revenue History

|
Show More
Show More

Blueprint Medicines Corporation Next Earnings Date & Report

BPMC Next Earnings Date & Report Preview: Dec 2021 (FQ)

BPMC's next earnings date is Tuesday, Feb 15, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Blueprint Medicines Corporation's next quarterly earnings is $-1.54, with a low EPS estimation of $-1.92, and a high estimation of $-1.20.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-1.54, the last 2 month trend is $-1.54, and the 3 month trend is $-1.53.

Based on analysts, the average revenue estimation is $56.49M, with a low revenue estimation of $39.30M, and a high estimation of $77.30M.

Blueprint Medicines Corporation Previous Earnings Dates & Reports

BPMC Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Blueprint Medicines Corporation's previous earnings date was Oct 28, 2021 for its fiscal quarter ended Sep 30, 2021.

BPMC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Blueprint Medicines Corporation's previous annual earnings date was Feb 17, 2021 for its fiscal year ended Dec 31, 2020.

BPMC's earnings per share (EPS) was $5.24, missing the consensus analysts forecast of $5.48 by -4.38% , and higher than the previous year's EPS (Dec 2019) by -171.78%.

Revenues were $793.74M, better than the forecast of $787.53M by 0.79%, and up by 1093.37% from previous year's revenue.

The company reported a net income of $313.88M.

Blueprint Medicines Corporation reported a free cash flow of $383.88M for its fiscal year, compared to $-292.03M a year ago.

The company ended the fiscal year with $89.60M in total debt, a decrease of -6.61% compared to the previous year.